Skip to main content
Top
Published in: Clinical Rheumatology 9/2017

01-09-2017 | Original Article

Autoantibodies against myelin sheath and S100β are associated with cognitive dysfunction in patients with rheumatoid arthritis

Authors: Talita Siara Almeida Baptista, Laura Esteves Petersen, Julia K. Molina, Tatiana de Nardi, Andréa Wieck, Aline do Prado, Deise Marcela Piovesan, Mauro Keisermann, Rodrigo Grassi-Oliveira, Moisés Evandro Bauer

Published in: Clinical Rheumatology | Issue 9/2017

Login to get access

Abstract

Rheumatoid arthritis (RA) has been associated with cognitive impairment and peripheral production of autoantibodies. Autoantibodies against central nervous system (CNS) proteins and S100 calcium-binding β (S100β) were found increased in diseases characterized by cognitive impairment like Alzheimer disease and Neuropsychiatric Systemic Lupus Erythematosus (NPSLE). The aim of this study was to investigate the plasma levels of autoantibodies against myelin basic protein (anti-MBP), myelin oligodendrocyte glycoprotein (anti-MOG) and S100β, and their relationships with cognitive performance in RA patients. Twenty patients with active rheumatoid arthritis and 19 age-, sex-, and schooling-matched healthy controls were recruited. Multiple dimensions of cognitive function were evaluated by structured clinical questionnaires. Autoantibodies and S100β levels were assessed by ELISAs. Patients had significantly higher levels of anti-MBP IgG (17.51 ± 1.36 vs. 5.24 ± 0.53 ng/mL), anti-MOG IgG (5.68 ± 1.34 vs. 0.51 ± 0.49 ng/mL), and S100β protein (2.24 ± 0.50 vs. 0.47 ± 0.06) than controls (all p < 0.0001). After adjusting for potential confounders, RA group presented worse cognitive performance involving the working memory and executive functions such as inhibition, flexibility, and mental control in parallel to higher autoantibodies and S100β levels than healthy controls (all p < 0.001). Levels of anti-MBP were negatively associated with delayed verbal recall (DVR; r = −0.42, p = 0.005), Stroop Color-Word (r = −0.48, p = 0.004), and N-Back Total scores (r = −0.59, p < 0.0001) and positively with Trail Making Test B (TMB, r = 0.53, p = 0.001). Negative correlation was found between levels of anti-MOG and DVR (r = −0.64, p < 0.0001), N-Back Total scores (r = −0.35, p = 0.03), Stroop Color-Word (r = −0.51, p = 0.001), and positively with TMB (r = 0.50, p = 0.003). S100β levels were associated with DVR (r = −0.51, p = 0.002), TMB (r = 0.46, p = 0.008), Stroop Color-Word (r = −0.67, p < 0.0001), and N-Back Total (r = −0.52, p = 0.003). RA is associated with impaired cognitive performance associated with higher levels of CNS-related autoantibodies and S100β levels. Given the importance of myelin integrity to cognition, our data indicate that these autoantibodies may be harmful to proper cognitive function.
Literature
1.
go back to reference Turesson C, Mathsson L, Jacobsson LT, Sturfelt G, Ronnelid J (2013) Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 72(12):2047–2048CrossRefPubMed Turesson C, Mathsson L, Jacobsson LT, Sturfelt G, Ronnelid J (2013) Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 72(12):2047–2048CrossRefPubMed
2.
go back to reference Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F (2011) Extra-articular manifestations of rheumatoid arthritis: an update. Autoimmun Rev 11(2):123–131CrossRefPubMed Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F (2011) Extra-articular manifestations of rheumatoid arthritis: an update. Autoimmun Rev 11(2):123–131CrossRefPubMed
3.
go back to reference Bartolini M, Candela M, Brugni M, Catena L, Mari F, Pomponio G et al (2002) Are behaviour and motor performances of rheumatoid arthritis patients influenced by subclinical cognitive impairments? A clinical and neuroimaging study. Clin Exp Rheumatol 20(4):491–497PubMed Bartolini M, Candela M, Brugni M, Catena L, Mari F, Pomponio G et al (2002) Are behaviour and motor performances of rheumatoid arthritis patients influenced by subclinical cognitive impairments? A clinical and neuroimaging study. Clin Exp Rheumatol 20(4):491–497PubMed
4.
go back to reference Hamed SA, Selim ZI, Elattar AM, Elserogy YM, Ahmed EA, Mohamed HO (2012) Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis. Clin Rheumatol 31(1):123–132CrossRefPubMed Hamed SA, Selim ZI, Elattar AM, Elserogy YM, Ahmed EA, Mohamed HO (2012) Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis. Clin Rheumatol 31(1):123–132CrossRefPubMed
5.
go back to reference Massardo L, Bravo-Zehnder M, Calderon J, Flores P, Padilla O, Aguirre JM et al (2015) Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus. Lupus 24(6):558–568CrossRefPubMed Massardo L, Bravo-Zehnder M, Calderon J, Flores P, Padilla O, Aguirre JM et al (2015) Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus. Lupus 24(6):558–568CrossRefPubMed
6.
go back to reference Di Domenico F, Pupo G, Giraldo E, Lloret A, Badia MC, Schinina ME et al (2016) Autoantibodies profile in matching CSF and serum from AD and aMCI patients: potential pathogenic role and link to oxidative damage. Curr Alzheimer Res 13(2):112–122CrossRefPubMed Di Domenico F, Pupo G, Giraldo E, Lloret A, Badia MC, Schinina ME et al (2016) Autoantibodies profile in matching CSF and serum from AD and aMCI patients: potential pathogenic role and link to oxidative damage. Curr Alzheimer Res 13(2):112–122CrossRefPubMed
7.
go back to reference Hagberg H, Mallard C (2005) Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol 18(2):117–123CrossRefPubMed Hagberg H, Mallard C (2005) Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol 18(2):117–123CrossRefPubMed
8.
go back to reference Nishioku T, Furusho K, Tomita A, Ohishi H, Dohgu S, Shuto H et al (2011) Potential role for S100A4 in the disruption of the blood-brain barrier in collagen-induced arthritic mice, an animal model of rheumatoid arthritis. Neuroscience 189:286–292CrossRefPubMed Nishioku T, Furusho K, Tomita A, Ohishi H, Dohgu S, Shuto H et al (2011) Potential role for S100A4 in the disruption of the blood-brain barrier in collagen-induced arthritic mice, an animal model of rheumatoid arthritis. Neuroscience 189:286–292CrossRefPubMed
9.
go back to reference Bargerstock E, Puvenna V, Iffland P, Falcone T, Hossain M, Vetter S et al (2014) Is peripheral immunity regulated by blood-brain barrier permeability changes? PLoS One 9(7):e101477CrossRefPubMedPubMedCentral Bargerstock E, Puvenna V, Iffland P, Falcone T, Hossain M, Vetter S et al (2014) Is peripheral immunity regulated by blood-brain barrier permeability changes? PLoS One 9(7):e101477CrossRefPubMedPubMedCentral
10.
go back to reference Yang XY, Lin J, Lu XY, Zhao XY (2008) Expression of S100B protein levels in serum and cerebrospinal fluid with different forms of neuropsychiatric systemic lupus erythematosus. Clin Rheumatol 27(3):353–357CrossRefPubMed Yang XY, Lin J, Lu XY, Zhao XY (2008) Expression of S100B protein levels in serum and cerebrospinal fluid with different forms of neuropsychiatric systemic lupus erythematosus. Clin Rheumatol 27(3):353–357CrossRefPubMed
11.
go back to reference Gruden MA, Davidova TB, Malisauskas M, Sewell RD, Voskresenskaya NI, Wilhelm K et al (2007) Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Abeta((25-35)) oligomers, S100b and neurotransmitters. J Neuroimmunol 186(1–2):181–192CrossRefPubMed Gruden MA, Davidova TB, Malisauskas M, Sewell RD, Voskresenskaya NI, Wilhelm K et al (2007) Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Abeta((25-35)) oligomers, S100b and neurotransmitters. J Neuroimmunol 186(1–2):181–192CrossRefPubMed
12.
go back to reference Barateiro A, Afonso V, Santos G, Cerqueira JJ, Brites D, van Horssen J, et al (2015) S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis. Mol Neurobiol Barateiro A, Afonso V, Santos G, Cerqueira JJ, Brites D, van Horssen J, et al (2015) S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis. Mol Neurobiol
13.
go back to reference Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K et al (2012) Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 64(5):640–647CrossRef Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K et al (2012) Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 64(5):640–647CrossRef
14.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324CrossRefPubMed
15.
go back to reference Beck AT, Steer RA, Ball R, Ranieri W (1996) Comparison of Beck depression inventories-IA and -II in psychiatric outpatients. J Pers Assess 67(3):588–597CrossRefPubMed Beck AT, Steer RA, Ball R, Ranieri W (1996) Comparison of Beck depression inventories-IA and -II in psychiatric outpatients. J Pers Assess 67(3):588–597CrossRefPubMed
16.
go back to reference Folstein MF, Folstein SE, McHugh PR (1975) "mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) "mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198CrossRefPubMed
17.
go back to reference Wechsler D (1987) WMS-R: Wechsler Memory Scale-Revised: Manual: Harcourt Brace Jovanovich Wechsler D (1987) WMS-R: Wechsler Memory Scale-Revised: Manual: Harcourt Brace Jovanovich
18.
go back to reference Owen AM, McMillan KM, Laird AR, Bullmore E (2005) N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Hum Brain Mapp 25(1):46–59CrossRefPubMed Owen AM, McMillan KM, Laird AR, Bullmore E (2005) N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Hum Brain Mapp 25(1):46–59CrossRefPubMed
19.
go back to reference Lezak MD (1995) Neuropsychological assessment. Oxford University Press, USA Lezak MD (1995) Neuropsychological assessment. Oxford University Press, USA
20.
go back to reference Guise BJ, Thompson MD, Greve KW, Bianchini KJ, West L (2014) Assessment of performance validity in the Stroop color and word test in mild traumatic brain injury patients: a criterion-groups validation design. J Neuropsychol 8(1):20–33CrossRefPubMed Guise BJ, Thompson MD, Greve KW, Bianchini KJ, West L (2014) Assessment of performance validity in the Stroop color and word test in mild traumatic brain injury patients: a criterion-groups validation design. J Neuropsychol 8(1):20–33CrossRefPubMed
21.
go back to reference Arbour N, Holz A, Sipe JC, Naniche D, Romine JS, Zyroff J et al (2003) A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis. J Neuroimmunol 137(1–2):197–209CrossRefPubMedPubMedCentral Arbour N, Holz A, Sipe JC, Naniche D, Romine JS, Zyroff J et al (2003) A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis. J Neuroimmunol 137(1–2):197–209CrossRefPubMedPubMedCentral
22.
go back to reference Boggs JM (2006) Myelin basic protein: a multifunctional protein. Cell Mol Life Sci 63(17):1945–1961CrossRefPubMed Boggs JM (2006) Myelin basic protein: a multifunctional protein. Cell Mol Life Sci 63(17):1945–1961CrossRefPubMed
23.
go back to reference Terao C, Ohmura K, Katayama M, Takahashi M, Kokubo M, Diop G et al (2011) Myelin basic protein as a novel genetic risk factor in rheumatoid arthritis--a genome-wide study combined with immunological analyses. PLoS One 6(6):e20457CrossRefPubMedPubMedCentral Terao C, Ohmura K, Katayama M, Takahashi M, Kokubo M, Diop G et al (2011) Myelin basic protein as a novel genetic risk factor in rheumatoid arthritis--a genome-wide study combined with immunological analyses. PLoS One 6(6):e20457CrossRefPubMedPubMedCentral
24.
go back to reference Girolamo F, Ferrara G, Strippoli M, Rizzi M, Errede M, Trojano M et al (2011) Cerebral cortex demyelination and oligodendrocyte precursor response to experimental autoimmune encephalomyelitis. Neurobiol Dis 43(3):678–689CrossRefPubMed Girolamo F, Ferrara G, Strippoli M, Rizzi M, Errede M, Trojano M et al (2011) Cerebral cortex demyelination and oligodendrocyte precursor response to experimental autoimmune encephalomyelitis. Neurobiol Dis 43(3):678–689CrossRefPubMed
25.
go back to reference Papuc E, Kurys-Denis E, Krupski W, Tatara M, Rejdak K (2015) Can antibodies against glial derived antigens be early biomarkers of hippocampal demyelination and memory loss in Alzheimer's disease? J Alzheimers Dis 48(1):115–121CrossRefPubMed Papuc E, Kurys-Denis E, Krupski W, Tatara M, Rejdak K (2015) Can antibodies against glial derived antigens be early biomarkers of hippocampal demyelination and memory loss in Alzheimer's disease? J Alzheimers Dis 48(1):115–121CrossRefPubMed
26.
go back to reference Sun X, Wang X, Chen T, Li T, Cao K, Lu A et al (2010) Myelin activates FAK/Akt/NF-kappaB pathways and provokes CR3-dependent inflammatory response in murine system. PLoS One 5(2):e9380CrossRefPubMedPubMedCentral Sun X, Wang X, Chen T, Li T, Cao K, Lu A et al (2010) Myelin activates FAK/Akt/NF-kappaB pathways and provokes CR3-dependent inflammatory response in murine system. PLoS One 5(2):e9380CrossRefPubMedPubMedCentral
27.
go back to reference Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K et al (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 8:184CrossRefPubMedPubMedCentral Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K et al (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 8:184CrossRefPubMedPubMedCentral
28.
go back to reference Kezuka T, Usui Y, Yamakawa N, Matsunaga Y, Matsuda R, Masuda M et al (2012) Relationship between NMO-antibody and anti-MOG antibody in optic neuritis. J Neuroophthalmol 32(2):107–110CrossRefPubMed Kezuka T, Usui Y, Yamakawa N, Matsunaga Y, Matsuda R, Masuda M et al (2012) Relationship between NMO-antibody and anti-MOG antibody in optic neuritis. J Neuroophthalmol 32(2):107–110CrossRefPubMed
29.
go back to reference Doronin VB, Parkhomenko TA, Castellazzi M, Padroni M, Pastore M, Buneva VN et al (2014) Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis. PLoS One 9(9):e107807CrossRefPubMedPubMedCentral Doronin VB, Parkhomenko TA, Castellazzi M, Padroni M, Pastore M, Buneva VN et al (2014) Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis. PLoS One 9(9):e107807CrossRefPubMedPubMedCentral
30.
go back to reference Pozsgay J, Babos F, Uray K, Magyar A, Gyulai G, Kiss E et al (2016) In vitro eradication of citrullinated protein specific B-lymphocytes of rheumatoid arthritis patients by targeted bifunctional nanoparticles. Arthritis Res Ther 18(1):15CrossRefPubMedPubMedCentral Pozsgay J, Babos F, Uray K, Magyar A, Gyulai G, Kiss E et al (2016) In vitro eradication of citrullinated protein specific B-lymphocytes of rheumatoid arthritis patients by targeted bifunctional nanoparticles. Arthritis Res Ther 18(1):15CrossRefPubMedPubMedCentral
31.
go back to reference Magalhaes R, Stiehl P, Morawietz L, Berek C, Krenn V (2002) Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch 441(5):415–427CrossRefPubMed Magalhaes R, Stiehl P, Morawietz L, Berek C, Krenn V (2002) Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch 441(5):415–427CrossRefPubMed
32.
go back to reference Domiciano DS, Carvalho JF, Shoenfeld Y (2009) Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases. Lupus 18(13):1233–1238CrossRefPubMed Domiciano DS, Carvalho JF, Shoenfeld Y (2009) Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases. Lupus 18(13):1233–1238CrossRefPubMed
33.
go back to reference Perry E, Kelly C, Eggleton P, De Soyza A, Hutchinson D (2014) The lung in ACPA-positive rheumatoid arthritis: an initiating site of injury? Rheumatology (Oxford) 53(11):1940–1950CrossRef Perry E, Kelly C, Eggleton P, De Soyza A, Hutchinson D (2014) The lung in ACPA-positive rheumatoid arthritis: an initiating site of injury? Rheumatology (Oxford) 53(11):1940–1950CrossRef
36.
go back to reference Nishioku T, Yamauchi A, Takata F, Watanabe T, Furusho K, Shuto H et al (2010) Disruption of the blood-brain barrier in collagen-induced arthritic mice. Neurosci Lett 482(3):208–211CrossRefPubMed Nishioku T, Yamauchi A, Takata F, Watanabe T, Furusho K, Shuto H et al (2010) Disruption of the blood-brain barrier in collagen-induced arthritic mice. Neurosci Lett 482(3):208–211CrossRefPubMed
38.
go back to reference Bartosik-Psujek H, Psujek M, Jaworski J, Stelmasiak Z (2011) Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone. Acta Neurol Scand 123(4):252–256CrossRefPubMed Bartosik-Psujek H, Psujek M, Jaworski J, Stelmasiak Z (2011) Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone. Acta Neurol Scand 123(4):252–256CrossRefPubMed
39.
go back to reference Tomassini V, De Giglio L, Reindl M, Russo P, Pestalozza I, Pantano P et al (2007) Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Mult Scler 13(9):1086–1094CrossRefPubMed Tomassini V, De Giglio L, Reindl M, Russo P, Pestalozza I, Pantano P et al (2007) Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Mult Scler 13(9):1086–1094CrossRefPubMed
40.
go back to reference Lu PH, Lee GJ, Tishler TA, Meghpara M, Thompson PM, Bartzokis G (2013) Myelin breakdown mediates age-related slowing in cognitive processing speed in healthy elderly men. Brain Cogn 81(1):131–138CrossRefPubMed Lu PH, Lee GJ, Tishler TA, Meghpara M, Thompson PM, Bartzokis G (2013) Myelin breakdown mediates age-related slowing in cognitive processing speed in healthy elderly men. Brain Cogn 81(1):131–138CrossRefPubMed
41.
go back to reference Bartzokis G (2005) Brain myelination in prevalent neuropsychiatric developmental disorders: primary and comorbid addiction. Adolesc Psychiatry 29:55–96PubMedPubMedCentral Bartzokis G (2005) Brain myelination in prevalent neuropsychiatric developmental disorders: primary and comorbid addiction. Adolesc Psychiatry 29:55–96PubMedPubMedCentral
42.
go back to reference Maetzler W, Berg D, Synofzik M, Brockmann K, Godau J, Melms A et al (2011) Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias. J Alzheimers Dis 26(1):171–179PubMed Maetzler W, Berg D, Synofzik M, Brockmann K, Godau J, Melms A et al (2011) Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias. J Alzheimers Dis 26(1):171–179PubMed
43.
go back to reference Coltman R, Spain A, Tsenkina Y, Fowler JH, Smith J, Scullion G et al (2011) Selective white matter pathology induces a specific impairment in spatial working memory. Neurobiol Aging 32(12):2324 e7-12 CrossRefPubMed Coltman R, Spain A, Tsenkina Y, Fowler JH, Smith J, Scullion G et al (2011) Selective white matter pathology induces a specific impairment in spatial working memory. Neurobiol Aging 32(12):2324 e7-12 CrossRefPubMed
44.
go back to reference Gonzalez-Gronow M, Cuchacovich M, Francos R, Cuchacovich S, Blanco A, Sandoval R et al (2015) Catalytic autoantibodies against myelin basic protein (MBP) isolated from serum of autistic children impair in vitro models of synaptic plasticity in rat hippocampus. J Neuroimmunol 287:1–8CrossRefPubMed Gonzalez-Gronow M, Cuchacovich M, Francos R, Cuchacovich S, Blanco A, Sandoval R et al (2015) Catalytic autoantibodies against myelin basic protein (MBP) isolated from serum of autistic children impair in vitro models of synaptic plasticity in rat hippocampus. J Neuroimmunol 287:1–8CrossRefPubMed
45.
go back to reference Bartzokis G, Lu PH, Tingus K, Mendez MF, Richard A, Peters DG et al (2010) Lifespan trajectory of myelin integrity and maximum motor speed. Neurobiol Aging 31(9):1554–1562CrossRefPubMed Bartzokis G, Lu PH, Tingus K, Mendez MF, Richard A, Peters DG et al (2010) Lifespan trajectory of myelin integrity and maximum motor speed. Neurobiol Aging 31(9):1554–1562CrossRefPubMed
46.
go back to reference Bartzokis G (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25(1):5–18 author reply 49-62 CrossRefPubMed Bartzokis G (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25(1):5–18 author reply 49-62 CrossRefPubMed
47.
go back to reference Appenzeller S, Bertolo MB, Costallat LT (2004) Cognitive impairment in rheumatoid arthritis. Methods Find Exp Clin Pharmacol 26(5):339–343CrossRefPubMed Appenzeller S, Bertolo MB, Costallat LT (2004) Cognitive impairment in rheumatoid arthritis. Methods Find Exp Clin Pharmacol 26(5):339–343CrossRefPubMed
48.
go back to reference Shin SY, Katz P, Wallhagen M, Julian L (2012) Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res (Hoboken). 64(8):1144–1150PubMedPubMedCentral Shin SY, Katz P, Wallhagen M, Julian L (2012) Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res (Hoboken). 64(8):1144–1150PubMedPubMedCentral
49.
go back to reference Sochocka M, Diniz BS, Leszek J (2016) Inflammatory response in the CNS: friend or foe? Mol Neurobiol Sochocka M, Diniz BS, Leszek J (2016) Inflammatory response in the CNS: friend or foe? Mol Neurobiol
50.
go back to reference Iaquinta M, McCrone S (2015) An integrative review of correlates and predictors of depression in patients with rheumatoid arthritis. Arch Psychiatr Nurs 29(5):265–278CrossRefPubMed Iaquinta M, McCrone S (2015) An integrative review of correlates and predictors of depression in patients with rheumatoid arthritis. Arch Psychiatr Nurs 29(5):265–278CrossRefPubMed
51.
go back to reference Coluccia D, Wolf OT, Kollias S, Roozendaal B, Forster A, de Quervain DJ (2008) Glucocorticoid therapy-induced memory deficits: acute versus chronic effects. J Neurosci 28(13):3474–3478CrossRefPubMed Coluccia D, Wolf OT, Kollias S, Roozendaal B, Forster A, de Quervain DJ (2008) Glucocorticoid therapy-induced memory deficits: acute versus chronic effects. J Neurosci 28(13):3474–3478CrossRefPubMed
Metadata
Title
Autoantibodies against myelin sheath and S100β are associated with cognitive dysfunction in patients with rheumatoid arthritis
Authors
Talita Siara Almeida Baptista
Laura Esteves Petersen
Julia K. Molina
Tatiana de Nardi
Andréa Wieck
Aline do Prado
Deise Marcela Piovesan
Mauro Keisermann
Rodrigo Grassi-Oliveira
Moisés Evandro Bauer
Publication date
01-09-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 9/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3724-4

Other articles of this Issue 9/2017

Clinical Rheumatology 9/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine